Cargando…
Real-life effectiveness and safety of secukinumab in axial spondyloarthritis: a single-center study
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9945485/ https://www.ncbi.nlm.nih.gov/pubmed/36583925 http://dx.doi.org/10.1097/CM9.0000000000002047 |
_version_ | 1784892151070457856 |
---|---|
author | Sun, Yuankai Wang, Jiajia Qiu, Yulu Lin, Shiyu Wang, Fang Tan, Wenfeng |
author_facet | Sun, Yuankai Wang, Jiajia Qiu, Yulu Lin, Shiyu Wang, Fang Tan, Wenfeng |
author_sort | Sun, Yuankai |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9945485 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-99454852023-02-23 Real-life effectiveness and safety of secukinumab in axial spondyloarthritis: a single-center study Sun, Yuankai Wang, Jiajia Qiu, Yulu Lin, Shiyu Wang, Fang Tan, Wenfeng Chin Med J (Engl) Correspondence Lippincott Williams & Wilkins 2022-11-05 2022-03-08 /pmc/articles/PMC9945485/ /pubmed/36583925 http://dx.doi.org/10.1097/CM9.0000000000002047 Text en Copyright © 2022 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) |
spellingShingle | Correspondence Sun, Yuankai Wang, Jiajia Qiu, Yulu Lin, Shiyu Wang, Fang Tan, Wenfeng Real-life effectiveness and safety of secukinumab in axial spondyloarthritis: a single-center study |
title | Real-life effectiveness and safety of secukinumab in axial spondyloarthritis: a single-center study |
title_full | Real-life effectiveness and safety of secukinumab in axial spondyloarthritis: a single-center study |
title_fullStr | Real-life effectiveness and safety of secukinumab in axial spondyloarthritis: a single-center study |
title_full_unstemmed | Real-life effectiveness and safety of secukinumab in axial spondyloarthritis: a single-center study |
title_short | Real-life effectiveness and safety of secukinumab in axial spondyloarthritis: a single-center study |
title_sort | real-life effectiveness and safety of secukinumab in axial spondyloarthritis: a single-center study |
topic | Correspondence |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9945485/ https://www.ncbi.nlm.nih.gov/pubmed/36583925 http://dx.doi.org/10.1097/CM9.0000000000002047 |
work_keys_str_mv | AT sunyuankai reallifeeffectivenessandsafetyofsecukinumabinaxialspondyloarthritisasinglecenterstudy AT wangjiajia reallifeeffectivenessandsafetyofsecukinumabinaxialspondyloarthritisasinglecenterstudy AT qiuyulu reallifeeffectivenessandsafetyofsecukinumabinaxialspondyloarthritisasinglecenterstudy AT linshiyu reallifeeffectivenessandsafetyofsecukinumabinaxialspondyloarthritisasinglecenterstudy AT wangfang reallifeeffectivenessandsafetyofsecukinumabinaxialspondyloarthritisasinglecenterstudy AT tanwenfeng reallifeeffectivenessandsafetyofsecukinumabinaxialspondyloarthritisasinglecenterstudy |